Key result
Catheter ablation provides safe and effective rhythm control versus antiarrhythmic medications in selected AF patients.
Why the study?
Does catheter ablation improve maintenance of sinus rhythm and reduce symptoms compared to antiarrhythmic drugs in patients with atrial fibrillation?
Does catheter ablation improve maintenance of sinus rhythm and reduce symptoms compared to antiarrhythmic drugs in patients with atrial fibrillation?
This review summarizes current evidence and guidelines supporting catheter ablation for rhythm control in atrial fibrillation, highlighting patient selection criteria and various ablation techniques.
Answers are grounded in this paper and cite their sources.
Supports ablation for selected AF patients now; leaves open optimal techniques and long-term outcomes in broader populations.
Catheter ablation therapy for atrial fibrillation (AF) has gained a significant role during maintenance of sinus rhythm compared to anti-arrhythmic medication. Catheter ablation techniques are also improved and progressed over years in parallel to better understanding of disease mechanisms and technological advancements. However, due to invasive nature of the therapy with its pertinent procedural risks, both appropriate patient selection and use of relevant approach should be considered by all electrophysiologists before decide to perform catheter ablation.
No takes yet. Share an insight, caveat, or question.
Koçyiğit et al. (2015) conducted a review in Atrial Fibrillation. Catheter ablation vs. Antiarrhythmic drugs was evaluated. Catheter ablation is an effective and safe therapeutic option for rhythm control in selected patients with atrial fibrillation compared to antiarrhythmic medications.
Synapse has enriched 10 related papers. Consider them for comparative context: